Paul McBarron
2015
In 2015, Paul McBarron earned a total compensation of $597.2K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary at Cyclacel Pharmaceuticals, a 72% increase compared to previous year.
Compensation breakdown
| Bonus | $111,749 |
|---|---|
| Option Awards | $143,963 |
| Salary | $319,283 |
| Other | $22,252 |
| Total | $597,247 |
McBarron received $319.3K in salary, accounting for 53% of the total pay in 2015.
McBarron also received $111.7K in bonus, $144K in option awards and $22.3K in other compensation.
Rankings
In 2015, Paul McBarron's compensation ranked 10,159th out of 13,638 executives tracked by ExecPay. In other words, McBarron earned more than 25.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,159 out of 13,638 | 26th |
Division Manufacturing | 3,871 out of 5,187 | 25th |
Major group Chemicals And Allied Products | 1,426 out of 1,857 | 23rd |
Industry group Drugs | 1,172 out of 1,531 | 23rd |
Industry Pharmaceutical Preparations | 913 out of 1,179 | 23rd |
Source: SEC filing on April 12, 2017.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2015.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020